StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) stock

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.04MP/E –Yield –

MiMedx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MiMedx's operating cash flow for the twelve months ending Sep 30, 2026 was $20.74M, down 69.4% year over year. For fiscal 2025 it was $74.00M, up 11.8% from the year before. Over ten years it grew 14.7% a year on average. The highest annual figure on record is $74.00M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$74.00M+11.8%
FY2024Dec 31, 2024$66.20M+147.2%
FY2023Dec 31, 2023$26.78M–
FY2022Dec 31, 2022-$17.89M–
FY2021Dec 31, 2021-$1.98M–
FY2020Dec 31, 2020-$30.26M–
FY2019Dec 31, 2019-$39.41M-210.1%
FY2018Dec 31, 2018$35.80M-43.1%
FY2017Dec 31, 2017$62.94M+163.9%
FY2016Dec 31, 2016$23.85M+26.8%
FY2015Dec 31, 2015$18.81M+11.9%
FY2014Dec 31, 2014$16.80M–
FY2013Dec 31, 2013-$284.00K–
FY2012Dec 31, 2012-$3.33M–
FY2011Dec 31, 2011-$6.66M–
FY2010Dec 31, 2010-$8.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.92M-86.6%
Q2 FY2026Jun 30, 2026-$10.02M-169.5%
Q1 FY2026Mar 31, 2026$1.88M-64.5%
Q4 FY2025Dec 31, 2025$24.96M+32.9%
Q3 FY2025Sep 30, 2025$29.33M+49.5%
Q2 FY2025Jun 30, 2025$14.42M-33.9%
Q1 FY2025Mar 31, 2025$5.30M-11.4%
Q4 FY2024Dec 31, 2024$18.78M+83.1%
Q3 FY2024Sep 30, 2024$19.62M+53.4%
Q2 FY2024Jun 30, 2024$21.81M+180.6%
Q1 FY2024Mar 31, 2024$5.98M–
Q4 FY2023Dec 31, 2023$10.26M–
Q3 FY2023Sep 30, 2023$12.79M+1233.8%
Q2 FY2023Jun 30, 2023$7.78M–
Q1 FY2023Mar 31, 2023-$4.05M–
Q4 FY2022Dec 31, 2022-$5.62M–
Q3 FY2022Sep 30, 2022$959.00K-84.8%
Q2 FY2022Jun 30, 2022-$3.01M-287.9%
Q1 FY2022Mar 31, 2022-$10.22M–
Q4 FY2021Dec 31, 2021-$3.23M–
Q3 FY2021Sep 30, 2021$6.33M–
Q2 FY2021Jun 30, 2021$1.60M–
Q1 FY2021Mar 31, 2021-$6.68M–
Q4 FY2020Dec 31, 2020-$10.27M–
Q3 FY2020Sep 30, 2020-$4.62M–
Q2 FY2020Jun 30, 2020-$3.10M-245.4%
Q1 FY2020Mar 31, 2020-$12.28M–
Q4 FY2019Dec 31, 2019-$23.12M-1607.3%
Q3 FY2019Sep 30, 2019-$3.16M-193.0%
Q2 FY2019Jun 30, 2019$2.13M-89.7%
Q1 FY2019Mar 31, 2019-$15.26M-250.0%
Q4 FY2018Dec 31, 2018$1.53M-92.6%
Q3 FY2018Sep 30, 2018$3.40M-81.1%
Q2 FY2018Jun 30, 2018$20.69M+53.4%
Q1 FY2018Mar 31, 2018$10.18M-4.4%
Q4 FY2017Dec 31, 2017$20.87M+41.9%
Q3 FY2017Sep 30, 2017$17.95M–
Q2 FY2017Jun 30, 2017$13.48M–
Q1 FY2017Mar 31, 2017$10.64M–
Q4 FY2016Dec 31, 2016$14.70M–

More MiMedx figures

See a number that looks wrong?